An experimental gene therapy developed by researchers at UCLA, University College London and Great Ormond Street Hospital has ...

Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the ...

New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...

An experimental gene therapy developed by researchers at UCLA, University College London and Great Ormond Street Hospital has ...

Researchers have discovered how sperm cells perform an extraordinary metabolic transformation after ejaculation, from quiet ...

A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for ...

Preclinical study showed PDIA1 and PDIA5 protect cells from oxidative stress, maintain mitochondrial function, and are involved in androgen receptor regulation.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Aicuris has reported the success of a phase 3 trial, which has demonstrated the superiority of oral antiviral pritelivir ...

Scientists have found a key weakness in prostate cancer cells. Two enzymes, PDIA1 and PDIA5, help cancer cells survive and ...

The proportion of people with heart failure receiving optimal therapy increased significantly with expansion of this ...

Neuronal ceroid lipofuscinosis type 1 (CLN1) disease, also known as infantile neuronal ceroid lipofuscinosis, is a rare and fatal neurodegenerative condition. CLN1 disease is caused by a deficiency in ...